Portfolio company
Artifex
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial vascular grafts for patients undergoing coronary and peripheral bypass surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vascular Graft Solutions
This company develops external support devices and surgical tools for vein grafts to improve outcomes in coronary and peripheral bypass surgeries for cardiac surgeons.
Vascular Graft Solutions (VGS)
This company develops surgical devices and external supports for vein grafts for cardiac surgeons and patients undergoing bypass surgery.
Healionics
Healionics produces synthetic vascular grafts for dialysis patients to improve blood access and reduce complications such as infection and occlusion.
Aortyx
This company develops bioresorbable endovascular patches and catheter delivery systems for surgeons to treat patients with aortic dissection and other vascular diseases.
CuroTis
This biotechnology company develops regenerative grafts that stimulate the body to grow patient-specific blood vessels for individuals requiring vascular access or organ regeneration.
Silk Biomaterials
This company develops silk-based implantable medical devices for tissue regeneration, including nerve conduits and vascular grafts, for clinicians and patients requiring surgical repair.
BioTube, Inc.
BioTube developing subcutaneous tissue-engineering moulds for creating autologous vascular grafts for patients requiring bypass surgery or regenerative medicine treatments.
OctoVascular
OctoVascular develops automated vessel connection technology for surgeons to perform minimally invasive coronary artery bypass surgery.
